BioCentury
ARTICLE | Company News

KV management update

July 26, 2010 7:00 AM UTC

KV Pharmaceutical Co. (NYSE:KVA), St. Louis, Mo. Business: Drug delivery, Generics Transitioned: Chief Accounting Officer Thomas McHugh to CFO; he served as interim CFO from September 2009 to April 20...